US 6028052
Treating NIDDM with RXR agonists
expired A61KA61K31/00A61K31/192
Quick answer
US patent 6028052 (Treating NIDDM with RXR agonists) held by Ligand Pharmaceuticals Incorporated expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 162
- CPC classes
- A61K, A61K31/00, A61K31/192, A61K31/425, A61K31/44